BMC Cancer

Table 2 The association between prevalent genotypes of human papilloma virus persistent positivity and cervical cancer clinical pathological data

From: The prevalence and role of human papillomavirus genotypes in primary cervical screening in the northeast of China

HPV persistent infection
Data	No. 1108	HPV +	χ ²	P	Multiple HPV(+)	χ ²	P	HPV 16+	χ ²	P	HPV 58+	χ ²	P	HPV 18+	χ ²	P	HPV 52+	χ ²	P	HPV 33+	χ ²	P
Age
<35	376	326	0.903	0.380	53	5.048	0.025	69	3.013	0.097	18	6.004	0.016	21	0.140	0.789	14	0.658	0.446	6	7.518	0.005
≥35	732	649			143			105			65			45			35			36
FIGO stage
Ia~Ib	643	562	0.511	0.513	115	0.040	0.873	91	2.786	0.112	55	2.497	0.133	38	0.006	1.000	28	0.017	0.884	26	0.269	0.636
IIa~IV	465	413			81			83			28			28			21			16
Grade	1069
G1 ~ G2	531	479	1.314	0.28	109	3.387	0.069	81	0.810	0.407	40	0.003	1.000	30	0.501	0.526	25	0.037	0.884	22	0.472	0.523
G3	538	496			87			93			41			36			24			18
Lymph metastasis	1043
no	739	692	0.800	0.417	135	0.094	0.792	113	3.533	0.068	54	1.077	0.312	36	9.074	0.005	34	0.000	1.000	27	0.914	0.386
yes	304	280			58			61			28			30			14			15
Histology
Squamous carcinoma	767	681	1.477	0.230	129	1.298	0.268	121	0.010	1.000	57	0.013	0.902	38	4.469	0.039	35	0.117	0.874	28	0.134	0.734
Adeno- carcinoma	341	294			67			53			26			28			14			14

Back to article page

ISSN: 1471-2407

Contact us

Submission enquiries: bmccancer@biomedcentral.com
General enquiries: ORSupport@springernature.com